Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Representational Photo The exploration of novel peptides for their potential impact on metabolic pathways has been a ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular ...

Some plans include clinical options like prescription drugs. Over the years, options like Semaglutide and Tirzepatide have ...